128 related articles for article (PubMed ID: 28846206)
1. Recombinant Domain V of Human Perlecan Is a Bioactive Vascular Proteoglycan.
Rnjak-Kovacina J; Tang F; Lin X; Whitelock JM; Lord MS
Biotechnol J; 2017 Dec; 12(12):. PubMed ID: 28846206
[TBL] [Abstract][Full Text] [Related]
2. Border patrol: insights into the unique role of perlecan/heparan sulfate proteoglycan 2 at cell and tissue borders.
Farach-Carson MC; Warren CR; Harrington DA; Carson DD
Matrix Biol; 2014 Feb; 34():64-79. PubMed ID: 24001398
[TBL] [Abstract][Full Text] [Related]
3. Mast cells produce novel shorter forms of perlecan that contain functional endorepellin: a role in angiogenesis and wound healing.
Jung M; Lord MS; Cheng B; Lyons JG; Alkhouri H; Hughes JM; McCarthy SJ; Iozzo RV; Whitelock JM
J Biol Chem; 2013 Feb; 288(5):3289-304. PubMed ID: 23235151
[TBL] [Abstract][Full Text] [Related]
4. Perlecan, a modular instructive proteoglycan with diverse functional properties.
Melrose J
Int J Biochem Cell Biol; 2020 Nov; 128():105849. PubMed ID: 32947020
[TBL] [Abstract][Full Text] [Related]
5. The role of vascular-derived perlecan in modulating cell adhesion, proliferation and growth factor signaling.
Lord MS; Chuang CY; Melrose J; Davies MJ; Iozzo RV; Whitelock JM
Matrix Biol; 2014 Apr; 35():112-22. PubMed ID: 24509440
[TBL] [Abstract][Full Text] [Related]
6. Perlecan domain V of Drosophila melanogaster. Sequence, recombinant analysis and tissue expression.
Friedrich MV; Schneider M; Timpl R; Baumgartner S
Eur J Biochem; 2000 Jun; 267(11):3149-59. PubMed ID: 10824099
[TBL] [Abstract][Full Text] [Related]
7. Cell surface chondroitin sulphate proteoglycan 4 (CSPG4) binds to the basement membrane heparan sulphate proteoglycan, perlecan, and is involved in cell adhesion.
Tang F; Lord MS; Stallcup WB; Whitelock JM
J Biochem; 2018 May; 163(5):399-412. PubMed ID: 29462330
[TBL] [Abstract][Full Text] [Related]
8. Perlecan and tumor angiogenesis.
Jiang X; Couchman JR
J Histochem Cytochem; 2003 Nov; 51(11):1393-410. PubMed ID: 14566013
[TBL] [Abstract][Full Text] [Related]
9. Myeloperoxidase-derived oxidants selectively disrupt the protein core of the heparan sulfate proteoglycan perlecan.
Rees MD; Whitelock JM; Malle E; Chuang CY; Iozzo RV; Nilasaroya A; Davies MJ
Matrix Biol; 2010 Jan; 29(1):63-73. PubMed ID: 19788922
[TBL] [Abstract][Full Text] [Related]
10. Silk biomaterials functionalized with recombinant domain V of human perlecan modulate endothelial cell and platelet interactions for vascular applications.
Rnjak-Kovacina J; Tang F; Whitelock JM; Lord MS
Colloids Surf B Biointerfaces; 2016 Dec; 148():130-138. PubMed ID: 27591944
[TBL] [Abstract][Full Text] [Related]
11. Widespread expression of perlecan proteoglycan in basement membranes and extracellular matrices of human tissues as detected by a novel monoclonal antibody against domain III and by in situ hybridization.
Murdoch AD; Liu B; Schwarting R; Tuan RS; Iozzo RV
J Histochem Cytochem; 1994 Feb; 42(2):239-49. PubMed ID: 7507142
[TBL] [Abstract][Full Text] [Related]
12. Effect of Recombinant Human Perlecan Domain V Tethering Method on Protein Orientation and Blood Contacting Activity on Polyvinyl Chloride.
Chandrasekar K; Farrugia BL; Johnson L; Marks D; Irving D; Elgundi Z; Lau K; Kim HN; Rnjak-Kovacina J; Bilek MM; Whitelock JM; Lord MS
Adv Healthc Mater; 2021 Jul; 10(14):e2100388. PubMed ID: 33890424
[TBL] [Abstract][Full Text] [Related]
13. Perlecan domain V inhibits amyloid-β induced brain endothelial cell toxicity and restores angiogenic function.
Parham C; Auckland L; Rachwal J; Clarke D; Bix G
J Alzheimers Dis; 2014; 38(2):415-23. PubMed ID: 23979025
[TBL] [Abstract][Full Text] [Related]
14. Expression of human perlecan domain I as a recombinant heparan sulfate proteoglycan with 20-kDa glycosaminoglycan chains.
Graham LD; Whitelock JM; Underwood PA
Biochem Biophys Res Commun; 1999 Mar; 256(3):542-8. PubMed ID: 10080934
[TBL] [Abstract][Full Text] [Related]
15. Perlecan--a multifunctional extracellular proteoglycan scaffold.
Farach-Carson MC; Carson DD
Glycobiology; 2007 Sep; 17(9):897-905. PubMed ID: 17442708
[TBL] [Abstract][Full Text] [Related]
16. Chondrogenic activity of the heparan sulfate proteoglycan perlecan maps to the N-terminal domain I.
French MM; Gomes RR; Timpl R; Höök M; Czymmek K; Farach-Carson MC; Carson DD
J Bone Miner Res; 2002 Jan; 17(1):48-55. PubMed ID: 11771669
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional complexity of the HSPG2 gene in the human mast cell line, HMC-1.
Lord MS; Jung M; Cheng B; Whitelock JM
Matrix Biol; 2014 Apr; 35():123-31. PubMed ID: 24365408
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factor-binding protein is a novel partner for perlecan protein core.
Mongiat M; Otto J; Oldershaw R; Ferrer F; Sato JD; Iozzo RV
J Biol Chem; 2001 Mar; 276(13):10263-71. PubMed ID: 11148217
[TBL] [Abstract][Full Text] [Related]
19. Perlecan from human epithelial cells is a hybrid heparan/chondroitin/keratan sulfate proteoglycan.
Knox S; Fosang AJ; Last K; Melrose J; Whitelock J
FEBS Lett; 2005 Sep; 579(22):5019-23. PubMed ID: 16129435
[TBL] [Abstract][Full Text] [Related]
20. Perlecan and its immunoglobulin like domain IV are abundant in vitreous and serum of the chick embryo.
Balasubramani M; Bier ME; Hummel S; Schneider WJ; Halfter W
Matrix Biol; 2004 Jun; 23(3):143-52. PubMed ID: 15296942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
